Trials / Completed
CompletedNCT05249803
"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19
"Clinical Characteristics, Comorbidities and Outcome of Critically Sick Patients With COVID-19 Pneumonia Admitted in Intensive Care Unit of a Tertiary Care Hospital in Lahore, Pakistan": A Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 133 (actual)
- Sponsor
- FMH College of Medicine and Dentistry · Academic / Other
- Sex
- All
- Age
- 16 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
COVID-19, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is a multisystem disease which primarily involves the respiratory tract. The first case of COVID-19 was identified in late 2019 in the province of Wuhan, China which was followed by the rapid spread of the disease globally, becoming a present-day pandemic. Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore.
Detailed description
Objectives: The aim of this study was to describe the clinical characteristics, comorbidities and outcome of the critically sick patients with COVID-19 pneumonia admitted in ICU of a tertiary care hospital in Lahore. Material \& Methods: Study design: Retrospective study. Study Settings: Study was conducted in Fatima Memorial Hospital, Lahore. Study Duration: Study was conducted on Covid-19 patients who were admitted from March 2021 to August 2021.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Patients with COVID-19 Pneumonia | Patients were offered with usual care of COVID-19 in ICU and we did retrospective study |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-08-31
- Completion
- 2021-12-31
- First posted
- 2022-02-22
- Last updated
- 2022-02-22
Locations
1 site across 1 country: Pakistan
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05249803. Inclusion in this directory is not an endorsement.